Cadrenal Therapeutics
CVKD
CVKD
3 hedge funds and large institutions have $429 invested in Cadrenal Therapeutics in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$408 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$6 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
1
Tower Research Capital (TRC)
New York
| $408 | 270 | -337 | -56% |
|
2
Wells Fargo
San Francisco,
California
| $15 | 10 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $6 | 4 | -226 | -98% |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|